The Norrie disease gene maps to a 150 kb region on chromosome Xp11.3. 1992

K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
Neuroscience Center (Neurology), Massachusetts General Hospital East, Charlestown 02129.

Norrie disease is a human X-linked recessive disorder of unknown etiology characterized by congenital blindness, sensory neural deafness and mental retardation. This disease gene was previously linked to the DXS7 (L1.28) locus and the MAO genes in band Xp11.3. We report here fine physical mapping of the obligate region containing the Norrie disease gene (NDP) defined by a recombination and by the smallest submicroscopic chromosomal deletion associated with Norrie disease identified to date. Analysis, using in addition two overlapping YAC clones from this region, allowed orientation of the MAOA and MAOB genes in a 5'-3'-3'-5' configuration. A recombination event between a (GT)n polymorphism in intron 2 of the MAOB gene and the NDP locus, in a family previously reported to have a recombination between DXS7 and NDP, delineates a flanking marker telomeric to this disease gene. An anonymous DNA probe, dc12, present in one of the YACs and in a patient with a submicroscopic deletion which includes MAOA and MAOB but not L1.28, serves as a flanking marker centromeric to the disease gene. An Alu-PCR fragment from the right arm of the MAO YAC (YMAO.AluR) is not deleted in this patient and also delineates the centromeric extent of the obligate disease region. The apparent order of these loci is telomere ... DXS7-MAOA-MAOB-NDP-dc12-YMAO.AluR ... centromere. Together these data define the obligate region containing the NDP gene to a chromosomal segment less than 150 kb.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D001766 Blindness The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE. Amaurosis,Bilateral Blindness,Blindness, Bilateral,Blindness, Legal,Blindness, Monocular,Blindness, Unilateral,Sudden Visual Loss,Unilateral Blindness,Blindness, Acquired,Blindness, Complete,Blindness, Hysterical,Blindness, Transient,Acquired Blindness,Amauroses,Bilateral Blindnesses,Complete Blindness,Hysterical Blindness,Legal Blindness,Monocular Blindness,Sudden Visual Losses,Transient Blindness,Visual Loss, Sudden
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D003638 Deafness A general term for the complete loss of the ability to hear from both ears. Deafness Permanent,Hearing Loss Permanent,Prelingual Deafness,Deaf Mutism,Deaf-Mutism,Deafness, Acquired,Hearing Loss, Complete,Hearing Loss, Extreme,Acquired Deafness,Complete Hearing Loss,Deafness, Prelingual,Extreme Hearing Loss,Permanent, Deafness,Permanent, Hearing Loss,Permanents, Deafness

Related Publications

K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
November 1995, American journal of human genetics,
K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
March 2023, American journal of ophthalmology case reports,
K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
November 1999, Genomics,
K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
January 2002, Neoplasia (New York, N.Y.),
K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
March 1991, Human genetics,
K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
November 2010, Journal of medical genetics,
K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
August 1996, Genomics,
K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
July 2002, Proceedings of the National Academy of Sciences of the United States of America,
K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
December 2004, The Journal of investigative dermatology,
K B Sims, and R V Lebo, and G Benson, and C Shalish, and D Schuback, and Z Y Chen, and G Bruns, and I W Craig, and M S Golbus, and X O Breakefield
March 1994, Nature genetics,
Copied contents to your clipboard!